Tecan stock last traded at CHF 230.20 on September 28, 2026

Tecan stock last traded at CHF 230.20 on September 28, 2026, up 3.14 percent from the previous close. The company confirmed its full-year 2026 outlook in its first-half report.

Tecan Group AG last traded at CHF 230.20 on the SIX Swiss Exchange on September 28, 2026, at 15:30:29 UTC. The shares were up CHF 7.00, or 3.14 percent, from the previous close of CHF 223.20.

First-half results and outlook

In an August 11, 2026 corporate release, Tecan reported first-half 2026 sales of CHF 427.5 million, representing growth of 3.40 percent in local currencies. The adjusted EBITDA margin was 15.10 percent. The company said both its Life Sciences Business and Partnering Business grew in local currencies during the period. Tecan confirmed its full-year 2026 sales outlook of low single-digit growth in local currencies and an adjusted EBITDA margin of 15.50 percent to 16.50 percent.

The same release said Tecan planned to publish a third-quarter update on November 5, 2026. The company also reiterated its medium-term 2028 outlook, including sales of CHF 1 billion and an adjusted EBITDA margin of 20 percent. The company release identified the figures as confirmed guidance.

Investor conference

On September 10, 2026, Tecan announced its planned participation in the Morgan Stanley Healthcare Conference in New York on September 14. The announcement said CEO Monica Manotas and CFO Camila Japur were scheduled to participate in the event. Tecan said a webcast would be available through its Investor Relations website.